Skip to content

Asia Pacific Precision Oncology Summit 2024

Join the Agilent Precision Oncology Summit to explore the latest in personalized cancer treatment. This year the summit begins with offering cutting-edge insights and practical guidance to enhance cancer care precision and effectiveness. Stay ahead in oncology and improve patient outcomes with precision medicine.

• Evaluation of PD-L1 in Gastric Cancer, Dr Chen Xiu Fen, Associate Consultant Pathologist, Singapore General Hospital, Singapore.
• Current and Emerging Biomarkers in Gastric Cancer Management – A Pathologist’s Perspective, Dr Brendan Pang, Consultant Pathologist, Avant-Garde Pathology, Singapore.
• Understanding PDL1 Assessment: Insights from Breast and Cervical Cancer Specimens, Dr Philippe Taniere, Consultant Histopathologist, University Hospitals Birmingham NHS Foundation Trust, United Kingdom.

 

 

Back To Top